UNH
UnitedHealth Group Incorporated$290.00
Hold
Target $373.88
Report: Feb 23, 2026Healthcare • Medical - Healthcare Plans • Mature CompounderSnapshot
Decision-first overview with recommendation, valuation anchor, and current setup.
Company Overview
Research Snapshot
Price History
Pelican View
Current$290.00+28.9%
Rec: HoldConviction: High
Entry Target
$287.60
(1% below current)
Fair Value
$373.88
(29% above current)
Stop Loss
$234.60
(19% below current)
Position Size
Half
Time Horizon
Long-Term
Key Metrics
Live Snapshot
Market Data
52 Week High$606.36
52 Week Low$234.60
Avg. 3 Month Volume9.58M
Efficiency
LTM Gross Margin18.5%
LTM EBITDA Margin5.0%
LTM EBIT Margin4.0%
LTM Operating Margin4.2%
LTM ROA3.9%
LTM ROE12.7%
LTM ROIC15.2%
LTM ROCE9.1%
Capital Structure
Market Cap (MM)$245.6B
Enterprise Value (MM)$299.6B
Shares Outstanding908.00M
Total Debt (MM)$78.39B
Cash & Equivalents (MM)$24.36B
LTM Net Debt (MM)$54.02B
LTM Net Debt/EBITDA2.4x
Growth
TTM Rev. Growth11.8%
Last 3-Yr Rev. CAGR11.4%
Last 3-Yr EBITDA CAGR-10.7%
Last 3-Yr EPS CAGR-14.9%
Valuation
Street Target Price$385.38
LTM EV/Revenue0.7x
LTM EV/Gross Profit3.6x
LTM EV/EBIT16.7x
LTM EV/EBITDA13.4x
LTM P/E20.4x
LTM EV/FCF18.6x
LTM P/FCF15.3x
LTM P/TB1.4x
LTM P/B2.6x
Dividend Yield3.2%
Payout Ratio65.8%
Executive SummarySituation: Current price is $290.0 versus fair value $373.88 (28.9% expected return), and valuation confidence is stable. Debate: Bull case depends on Realization of $1 billion in AI-enabled operating cost reductions in FY 2026. Bear case centers on DOJ Antitrust Investigation into Vertical Integration. Conclusion: Recommendation is Hold with Half sizing and Long-Term horizon.
Bull Case
The Optum flywheel captures value across the entire care continuum that traditional insurers cannot access; AI-driven cost reductions are projected to save $1 billion annually starting in 2026.
Bear Case
The DOJ antitrust probe could lead to a forced divestiture of Optum, breaking the vertical integration moat; V28 Medicare Advantage cuts and rising medical cost trends (7.5-11%) may permanently impair margins.
Key Catalysts
Mid-Term (6-18 months)Impact: High
Realization of $1 billion in AI-enabled operating cost reductions in FY 2026. This will validate management's claim that technology can offs...
Near-Term (0-6 months)Impact: Critical
Stabilization of the Medical Care Ratio (MCR) at 88.8% +/- 50 basis points. Achieving this target would signal that the intentional membersh...
Long-Term (18+ months)Impact: Moderate
UnitedHealth is at a critical juncture following the return of Stephen Hemsley and the announcement of a massive strategic pivot toward marg...
Primary Risks
Concern: High
DOJ Antitrust Investigation into Vertical Integration. A forced divestiture of Optum would break the 'flywheel' that allows UNH to capture s...
Concern: Medium
V28 Medicare Advantage Payment Cuts. Permanent reductions in reimbursement rates could exceed the company's ability to cut costs, leading to...
Concern: Medium
The governance outlook is defined by the following tree: 1. Status Quo: Hemsley successfully executes the margin recovery plan, restoring th...
Recent Activity
2026-01-27SEC Filing (8-K)
-19.61%UnitedHealth Group reports full year 2025 results and issues 2026 outlook with revenue guidance exceeding $439.0 billion.
2025-09-09SEC Filing (8-K)
+8.64%UnitedHealth Group reaffirms 2025 earnings outlook
2025-08-15Press Release
+11.98%Twilio Set To Join S&P Midcap 400
2025-07-31SEC Filing (8-K)
-6.19%UnitedHealth Group announces CFO leadership transition
2025-07-29SEC Filing (8-K)
-7.46%UnitedHealth Group re-establishes full year 2025 outlook with revenue of $445.5-448.0B and earnings of at least $14.65 per share.
Valuation Table
9.8/10Decision Grade
Scenario Range
$298
Bear
$290